Valuation: Mega Lifesciences

Market Cap 30.95B 930M 814M 752M 702M 1.32B 87.92B 1.35B 9.05B 3.49B 43.38B 3.49B 3.42B 151B P/E 2026 *
13.3x
P/E 2027 * 12.6x
Enterprise Value 26.1B 784M 687M 634M 592M 1.11B 74.14B 1.14B 7.63B 2.94B 36.58B 2.94B 2.88B 127B EV / Sales 2026 *
1.75x
EV / Sales 2027 * 1.68x
Free-Float
38.61%
Yield 2026 *
5%
Yield 2027 * 5.28%
1 day+1.43%
1 week+1.43%
Current month-1.39%
1 month+2.90%
3 months+3.65%
6 months+9.23%
Current year+5.97%
1 week 34
Extreme 34
35.75
1 month 33.75
Extreme 33.75
36
Current year 31.5
Extreme 31.5
40
1 year 25
Extreme 25
40
3 years 24.3
Extreme 24.3
46.75
5 years 24.3
Extreme 24.3
56.5
10 years 15.9
Extreme 15.9
56.5
Manager TitleAgeSince
Chief Executive Officer 64 01/01/1988
Director of Finance/CFO 61 01/01/1997
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 61 01/01/1998
Director/Board Member 64 01/01/2013
Director/Board Member 73 01/02/2013
Date Insider Type Main position Quantity % Market Cap.
29/04/25Buy

Chief Executive Officer

100,000 0.0115%
28/04/25Buy

Chief Executive Officer

50,000 0.0057%
28/04/25Buy

Chief Executive Officer

50,000 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
+1.43%+1.43%+37.86%-1.39% 915M
+1.81%+11.60%+57.78%+164.79% 1,077B
+1.51%+11.77%+69.24%+57.53% 613B
+0.38%+10.56%+37.01%+90.88% 448B
+1.86%+4.85%+28.17%+22.04% 332B
-0.14%+8.04%+39.85%+27.27% 293B
-0.06%+6.68%+31.21%+42.55% 286B
-0.96%+7.49%-28.02%-40.86% 215B
+0.62%+4.59%+29.13%+63.03% 193B
-1.21%+1.17%+13.94%+66.20% 159B
Average +0.45%+7.99%+31.62%+49.20% 361.7B
Weighted average by Cap. +0.74%+9.65%+42.32%+81.53%

Financials

2026 *2027 *
Net sales 14.88B 447M 391M 361M 337M 635M 42.26B 650M 4.35B 1.68B 20.85B 1.68B 1.64B 72.38B 15.61B 469M 411M 379M 354M 667M 44.35B 682M 4.56B 1.76B 21.88B 1.76B 1.72B 75.96B
Net income 2.32B 69.71M 61.04M 56.35M 52.62M 99.05M 6.59B 101M 678M 262M 3.25B 262M 256M 11.29B 2.46B 73.91M 64.72M 59.75M 55.79M 105M 6.99B 107M 719M 278M 3.45B 278M 271M 11.97B
Net Debt -4.85B -146M -128M -118M -110M -207M -13.78B -212M -1.42B -548M -6.8B -548M -536M -23.61B -4.76B -143M -125M -116M -108M -203M -13.51B -208M -1.39B -537M -6.67B -537M -525M -23.14B
Logo Mega Lifesciences
Mega Lifesciences Public Company Limited is a Thailand-based company, which is engaged in health and wellness industry. Its segments include Brands, Distribution and OEM. MEGA We Care is its branded products business, through which it develops, manufactures, markets and sells its own range of nutraceuticals, complementary medicines, prescription pharmaceuticals and over the counter (OTC) health products. Maxxcare serves as its prominent distribution arm, specializing in the marketing, sales, and distribution of a range of branded prescription pharmaceuticals, OTC medications and fast-moving consumer goods (FMCG) across key markets such as Myanmar, Vietnam and Cambodia. Its suite of services encompasses warehouse management, collections and value-added initiatives, including tailored marketing services for principals in the pharmaceutical and FMCG sectors. Its manufacturing facilities in Thailand, Australia and Indonesia also accept production orders from various third-party customers.
Employees
-
Date Price Change Volume
29/06/26 THB 35.50 +1.43% 1,738,337
26/06/26 THB 35.00 -0.71% 1,092,935
25/06/26 THB 35.25 +2.17% 1,113,715
24/06/26 THB 34.50 +0.73% 370,797
23/06/26 THB 34.25 -1.44% 546,634
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
35.50THB
Average target price
41.14THB
Spread / Average Target
+15.90%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEGA Stock